IG
REGN icon

Ithaka Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Ithaka Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,392
Closed -$14.8M – 42
2017
Q4 		$14.8M Sell
39,392
-732
-2% -$296K 2.66% 15
2017
Q3 		$17.9M Sell
40,124
-2,216
-5% -$1.05M 3.3% 11
2017
Q2 		$20.8M Buy
42,340
+40
+0.1% +$17.5K 3.78% 12
2017
Q1 		$16.4M Sell
42,300
-3,433
-8% -$1.27M 3.17% 12
2016
Q4 		$16.8M Sell
45,733
-8,535
-16% -$3.25M 3.31% 11
2016
Q3 		$21.8M Sell
54,268
-9,125
-14% -$3.66M 3.43% 11
2016
Q2 		$22.1M Sell
63,393
-1,148
-2% -$442K 3.21% 11
2016
Q1 		$23.3M Buy
64,541
+1,007
+2% +$415K 3.36% 12
2015
Q4 		$34.5M Buy
63,534
+4,195
+7% +$2.27M 4.6% 8
2015
Q3 		$27.6M Buy
59,339
+7,560
+15% +$4.06M 4.24% 8
2015
Q2 		$26.4M Sell
51,779
-4,184
-7% -$2.04M 4.44% 5
2015
Q1 		$25.3M Buy
55,963
+2,640
+5% +$1.12M 4% 7
2014
Q4 		$21.9M Sell
53,323
-4,633
-8% -$1.82M 3.43% 11
2014
Q3 		$20.9M Sell
57,956
-2,193
-4% -$735K 3.13% 12
2014
Q2 		$17M Buy
60,149
+21,235
+55% +$6.29M 2.46% 20
2014
Q1 		$11.7M Buy
38,914
+5,358
+16% +$1.65M 1.94% 27
2013
Q4 		$9.24M Buy
33,556
+4,290
+15% +$1.23M 1.74% 28
2013
Q3 		$9.16M Buy
29,266
+1,521
+5% +$400K 2.13% 23
2013
Q2 		$6.24M Buy
+27,745
New +$6.46M 1.83% 29

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Ithaka Group's REGN Position: Q1 2018 in Review

Ithaka Group sold out of Regeneron Pharmaceuticals (REGN) in Q1 2018, closing a stake of 39,392 shares — an estimated $14.8M sold.

Ithaka Group first reported a position in REGN in Q2 2013 and held it in 19 quarters. The position peaked at $34.5M in Q4 2015. 620 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • Ithaka Group reported no remaining Regeneron Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Ithaka Group sold 39,392 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $14.8M.
  • Ithaka Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • Ithaka Group's Regeneron Pharmaceuticals position peaked at $34.5M in Q4 2015.
  • 620 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Ithaka Group's 13F filing for Q1 2018, filed 14 May 2018.